Eli Lilly Sponsors Shaq's Dunkman League as Qualifying Starts

Eli Lilly, the drugmaker that booked $65 billion last year, signed on in April 2026 as a sponsor of the Dunkman League, the professional circuit founded by NBA Hall of Famer Shaquille O'Neal. Qualifying events for the league begin this weekend.

The deal pairs the pharmaceutical giant with the world's first and only professional sports league dedicated entirely to competitive dunking. O'Neal started the league and serves as its commissioner.

What is the Dunkman League?

The format is straightforward. Dunkers from around the world compete through multiple group-stage qualifying events, which feed a live World Championship. The competitors hold guaranteed contracts and chase a $1 million prize. The league also runs a junior division for athletes 15 and under.

Judging is equally simple. Each dunking attempt is scored on five criteria: difficulty, execution, originality, power, and vertical leap. The closest comparison is the NBA dunk contest held during All-Star weekend, but the Dunkman League runs a full competitive structure around the discipline rather than a single exhibition night.

Why did Eli Lilly sign on?

The connection runs through O'Neal himself. Shaq is a spokesman for Zepbound, one of Eli Lilly's flagship products alongside Mounjaro, the company's diabetes and weight-reducing drugs that drove its $65 billion in revenue last year. The sponsorship extends an existing commercial relationship into a new property.

O'Neal described the partnership as mutually beneficial, and framed it around the unseen work behind the sport's highlight moments.

"Everybody sees the highlight reel. I see the hundred dunks they missed before they landed that one, and all the hours nobody sees in the gym, in the weight room, and resting up so they can do it all again," O'Neal told Inc. "Health is what keeps you getting back up, and that's why I'm glad Lilly's in our corner."

The quote does the strategic work. It ties a dunking spectacle to health, recovery, and conditioning — the territory Eli Lilly occupies with its metabolic drug portfolio. The sponsorship is not primarily about selling tickets to a dunking championship; it is about attaching the Lilly name, through a trusted athlete-spokesman, to a message about sustained physical performance.

What does the sponsorship signal?

The structure of the league gives sponsors a controlled, media-friendly product: short judged attempts, defined criteria, a $1 million prize purse, guaranteed contracts for competitors, and a youth division that widens the audience base. For a company whose weight-loss and diabetes brands depend on broad consumer awareness, that package offers recurring exposure across qualifying weekends and a championship event, not a one-night ad slot.

The existing Zepbound relationship lowers the risk. Lilly is not betting on an untested endorser; it is expanding a partnership with O'Neal that already exists in its consumer marketing.

With qualifying starting this weekend, the league now moves from concept to competition under a sponsor that spent $65 billion's worth of last year building the health brand Shaq is selling alongside the dunks.